Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / COM NEW
Symbol
SONN
Price per share
$4.58
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
21,198,794
Total reported value
$97,089,813
% of total 13F portfolios
0%
Share change
+21,018,388
Value change
+$96,755,407
Number of holders
28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 28 institutional investors reported holding 21,198,794 shares of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN).

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 37,185 $170,307 +$170,160 $4.58 1
2025 Q3 21,198,794 $97,089,813 +$96,755,407 $4.58 28
2025 Q2 180,406 $223,703 +$23,757 $1.24 9
2025 Q1 161,246 $216,070 +$86,656 $1.34 7
2024 Q4 89,070 $130,157 +$129,510 $1.46 9
2024 Q3 443 $2,964 +$2,529 $6.69 2